7 employees
TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases
2013
$25M
from 4 investors over 4 rounds
TenNor Therapeutics raised $25M on September 19, 2016
Investors: RELATIVITY HEALTHCARE PARTNERS, LLC, Frontline BioVentures, Northern Light Venture Capital and Oriza Ventures